29 April - 1 May 2011
An emerging concept in cancer biology is that a subset of cancer cells among the heterogeneous cell mass that constitutes the tumour may drive the growth of the tumour. This so-called “cancer stem cell” (CSC) has the ability to self-renewal, differentiate into all the cell types of the original cancer and reinitiate the tumour upon transplantation. Despite of the clear importance of CSCs in the genesis and perpetuation of cancers, little is currently known about the biological and molecular properties that make CSCs distinct from normal stem cells, the developmental/cellular origin of CSCs, and identification of candidate molecular targets for therapeutic intervention. Furthermore, the implications of the microenvironment in the maintenance of CSCs are just emerging. This symposium will try to shed new lights into: - Pathways important for self-renewal of normal and/or CSCs, - The heterogeneity of the CSCs - New avenues to target CSCs - Visualisation of the CSCs niche Targeted audience: Researchers already in the field (or wishing to enter it), clinicians implicated in novel targeted therapies, students and biologists of solid tumour or hematology laboratories.
]]>6 - 8 April 2011
Stem cell biology is progressing rapidly. The unraveling of cell mechanisms is leading to new concepts and strategies for clinical intervention, including disease modeling, drug screening and cell therapy. The conference will bring together research stakeholders, including stem cell biologists grappling with the complexity of cell fate determination, bioimaging and those using stem cells in patients.
The event is co-sponsored by the ‘European consortium for systematic stem cell biology’ (Eurosystem) project. Funded by the Seventh Framework Programme (FP7), Eurosystem aims to interlink complementary biological and computational expertise so as to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. Project participants include universities, small to medium businesses (SMEs) and researchers from the public and private sectors.
http://www.pasteur.fr/infosci/conf/sb/stemcell2011
]]>
25-27 March 2011
Following the success of the European School of Haematology conference with similar focus held in Tunisia in October 2010, the purpose of this meeting will be to provide an update on « gold standards » in the diagnostic procedures, evaluation of prognosis and treatment of all types of haematological malignancies. Therefore, procedures having shown their “robustness” and treatments having clearly demonstrated a benefit in outcome will be emphasized, rather than research procedures or treatments. This symposium should be of particular interest to specialists treating haematological malignancies, including younger physicians. It may also suit haematologists from less economically developed countries who want to introduce only widely validated procedures and treatments.
The conference will be chaired by B. Löwenberg, M. Elalfy, E. Gluckman and P. Fenaux.
November 2011
The World Conference on Regenerative Medicine (WRM) has laid a further milestone for Leipzig and its impact in regenerative medicine. The main topics addressed will be: Stem Cells (Neuronal and Cardiac, Liver and Diabetes, Plurpotency and Cell Reprogramming, Oncology and Tumor Stem Cells), Tissue Engineering (Vascular Remodeling and Angiogenesis, Cartilage and Bone Engineering, Biomaterials and Scaffols, Material Surfaces and Implants), Technology Development (Bioreactor Development, Drug Delivery, Imaging, Diagnostics), Immunology and Signaling (Acceptance of Allografts, Tolerance Mechanism, Graft vs. Host Disease, Metabolism and Signal Transduction), Regulatory Affairs (Manufacturing, Quality Control and Marketing, Cell Products and Diagnostics, Clinical Trials, Pre-clinical Studies and Legal Affairs, Funding and International Networks).
]]>17-19 December 2010
The conference will focus on the following topics: reprogramming of stem cell, chemical biology research in stem cell, applied research in embryonic and somatic stem cells, stem cell and drug R&D, development and mode animal research, stem cell biology and cloning. The conference will invite members of the Chinese Academy of Sciences Overseas Innovation Team on stem cells and cloning, expert panel members of the national key project on Development and Procreation, the nation’s 973 Project chief scientists and other professionals of the area from all over the world.
This conference is sponsored by the Department of Basic Research, Ministry of Science and Technology (MOST), the Institute of Life Sciences and Biological Technology, Chinese Academy of Sciences (CAS), the Science and Technology Department of Guangdong Province, the Science and Technology Department of Guangzhou Municipal Government and the Chinese Society for Cell Biology. The organizer is the Guangzhou Institute of Biomedicine and Health, CAS, with the support of Guangzhou Biological Engineering Center.
27 - 29 October 2011
The upcoming WORLD CORD BLOOD CONGRESS will cover a wide range of topics including cord blood transplant in adults and children, the role of HLA in cord blood transplant, stem cells, cord blood banking and regulatory issues.
http://www.esh.org/conference/esh-eurocord-eurocord-ed-netcord-ebmt-world-cord-blood-congress/
]]>1 – 3 December 2010
The symposium is organized every year by the Berlin-Brandenburg School for Regenerative Therapies (BSRT). It looks into several aspects of regenerative medicine and is mainly addressed to PhD students.
Presentations will be given by scientists and students on such topics as: “isolation and manipulation of stem cells”, “stem cells in medical applications”, “applications, limitations and safety” or “induced pluripotent stem cells: future prospects for pharma and the clinic”.
http://www.bsrt-phdsymposium.de/index.php?option=com_frontpage&Itemid=370
]]>14-16 October 2011
More information on the programme will be available soon.
http://www.esh.org/conference/esh-eha-scientific-workshop-aml-molecular/
]]>7 October 2010
The production of iPS cells from dermal fibroblasts has generated intense interest in the utility of such cells for research purposes and clinical applications. iPS cell production currently requires the use of transcription factor gene delivery to reprogramme cells into iPS cells. Hence, both gene delivery technology and iPS cell characterization and subsequent cell differentiation are critical aspects of iPS cell biology. This meeting will address both issues.
Main topics : Human ESCs into specific endodermal cell types, Stem cell states and the single cell, Derivation and utility of cardiomyocytes from human pluripotent stem cells, Reprogramming: from Technology to Biology.
http://www.regonline.co.uk/builder/site/Default.aspx?eventid=645255
]]>